Managing Director - Equity Research Biotechnology

Advisor Group•New York, NY

3d•Onsite

About The Position

Ladenburg Thalmann & Co. Inc. seeks a highly talented individual to add significant value to our equity research team. This individual will prepare and execute analyses of specific areas within biotechnology, with a focus on commercial and clinical stage companies across a wide range of therapy areas: cardiology, endocrine, ID, and radiopharmaceuticals. The ideal candidate will have an innovative mindset, relentless intellectual curiosity, a passion for biotech innovation and the stock market, and be a team player in a fast-paced environment.

Requirements

10+ years of equity research and publishing experience at a sell-side investment bank.
A deep understanding of the biotechnology and pharmaceutical industries, including clinical development, regulatory affairs, business development, and commercialization.
Strong Excel, Word, PowerPoint, and CapitalIQ skills.
Detailed financial modeling and equity valuation experience.
Series 7, 86, and 87 licensed.
Excellent written & verbal communication skills and strong multi-tasking ability.
Ability to search, understand, and synthesize scientific and medical publications.

Nice To Haves

MD, CFA, or MBA preferred.

Responsibilities

Formulate investment recommendations based on fundamental analysis, valuation, and risk assessment of individual companies.
Leverage a scientific and financial mindset in writing research reports on companies for distribution to the sales force and institutional clients.
Collect and analyze data (i.e., scientific papers, clinical trial data) related to novel therapeutics in immunologic diseases.
Conduct regular meetings with public and private companies to develop and maintain relationships.
Build, update, and maintain financial models to inform investment recommendations.
Keep up to date on all sector-relevant market news and medical meeting presentations.
All other duties as assigned